← Back
$ALDX All transactions

Aldeyra Therapeutics, Inc.

▼ SELL

$ Value

$114K

Shares

22,073

Price

$5

Filed

Aug 13

Insider

Name

Machatha Stephen

Title

Chief Development Officer

CIK

0001836354

Roles

Officer

Transaction Details

Transaction Date

2025-08-11

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

221,799

Footnotes

These shares of common stock were sold in a transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $5.06 to $5.29. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. | Includes 7,101 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0000950170-25-108210

Form Type

4

Issuer CIK

0001341235

Machatha Stephen's History

Date Ticker Type Value
2025-08-11 ALDX $114K

Other Insiders at ALDX (90d)

Insider Bought Sold Last
Brady Todd C
President and CEO
2026-03-27